Navigation Links
Lilly Reports Solid First-Quarter Results
Date:4/21/2008

N/M

Asset impairments,

restructuring and other

special charges 145.7 123.0 N/M

--------- ---------

Operating income 1,036.0 681.1 52 %

Net interest income

(expense) (3.5) 4.0

Joint-venture income 0.0 11.0

Net other income 23.8 23.3

--------- ---------

Other income 20.3 38.3

Income before income taxes 1,056.3 719.4 47 %

Income taxes (8.0) 210.7 N/M

--------- ---------

Net income $ 1,064.3 $ 508.7 109 %

--------- ---------

Earnings per share -

basic $ 0.97 $ 0.47 106 %

--------- ---------

Earnings per share -

diluted $ 0.97 $ 0.47 106 %

--------- ---------

Dividends paid per share $ 0.47 $ 0.425 11 %

Weighted-average shares

outstanding (thousands) -

basic 1,093,866 1,089,732

Weighted-average shares

outstanding (thousands) -

diluted 1,094,056 1,089,879

N/M - not meaningful

Eli Lilly and Company

Operating Results (Unaudited) - PRO FORMA

(Dollars in millions, except per share data)

Three Months Ended

March 31

2008 2007(a) % Chg.

--------------------------------

Net sales $ 4,807.6 $ 4,298.8 12 % '/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
2. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
3. Lilly Announces Termination of AIR Insulin Program
4. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
7. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
8. Lilly Declares Fourth-Quarter Dividend
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )t...StockMarketthattradinginthecompany,scommonstockwil...befiledwiththe,SecuritiesandExchangeCommission,whi...q,unlessthecompanyfilesanappealtotheNasdaq,Listing...,which,willstaythesuspensionanddelistingthroughthe...
(Date:11/24/2009)...tCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmace...novelpainmanagementtherapies,announcedtodaythatAnt...heduledtopresentatthe21stAnnualPiperJaffrayHealthC...PalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoandS...bletorespondtoquestionsduringthepresentationsandto...
(Date:11/24/2009)...RNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HTL)...ncedlasersystemsandinstrumentsforthestemcellresear...alandfinancialresultsforthethirdquarterendedSeptem...millioncomparedwith$1.43millioninQ32008,-Grossprof...2008,-Netlossreducedto$148,000comparedto$283,000in...
(Date:11/24/2009)...tomers with Partners Validated to Process and Anal... Ottawa, ON (PRWEB) Novemb...f products for biological sample collection, stabi...global partner program. The program offers signifi...ity and is designed to help partners scale and dif...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...S, Oct. 15 Strategic Healthcare,Group LLC announc...with the,American Red Cross to provide Strategic B...100 American Red Cross client hospitals across the...ighly successful Strategic Blood,Management(TM) pr...,Birmingham Hospital and Baptist Hospital in Pensa...
...a., Oct. 15 Cryo-Cell,International, Inc. (OTC Bu...rld,s largest and most established family cord blo...arter and nine months ended August 31,2008., Cons...ximately $4.5,million compared to approximately $4...any reported a net loss in the third quarter 2008 ...
...ent Medical Education Agency Expanding Industry Co...hcare,Communications LLC, an independent, full-ser... hiring of Todd Weinstein as Vice President, Busin...erience in medical education and,publishing as the...M, he,served as Manager of Publication Sales at Mc...
Other Biology Technology:American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion 2
(Date:11/25/2009)...at may be just as vital to your health as what you...Biological Studies. Their experiments in mice reve... of genes in the liverthe body,s metabolic clearin...by the body,s circadian clock as conventional wisd...tivity of a large number of genes completely indep...
(Date:11/24/2009)...tute (LRI) today named 12 new grant recipients for...e innovative work across a broad spectrum of lupus... novelty, and potential to drive scientific discov...plex disease of systemic lupus. , The 2009 grant... across the nation and include interdisciplinary a...
(Date:11/24/2009)...ised a protein that may help gut bacteria bind to ...sed by probiotic producers to identify strains tha...Probiotics need to interact with cells lining the ...h to surfaces in the gut they are more likely to s...says Dr Nathalie Juge from the Institute of Food R...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 1Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 2Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 1Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 1Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 3
... Screening for mutations in a gene that helps the...n drug may predict which children are at higher ri...lood cell count or organ rejection, according to n...ature journal Clinical Pharmacology and Therapeu...uld also help physicians tailor personalized anti-...
...s often thought of as harmful yet few know that ba... research the role of bacteria in water treatment,...ing with three leading institutions across three c...f cell-to-cell communication in bacteria. A greate... come up with better solutions for water and waste...
...ated Ocean Drilling Program (IODP) will conduct sc...e of its platforms in 2009, from March until Decem...tions in 2004 that all three platforms will operat...ed aboard the Chikyu; the newly modernized JOIDES ...ion-specific operations will be conducted using pl...
Other Biology News:Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants 2Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants 3NTU seals global partnerships on environmental sciences R&D 2IODP to operate 3 drilling platforms in 2009 2
iEMS Incubator/Shaker 2 module from Thermo Scientific
...is a modified cap analog in which the 3 OH group (...his substitution, the RNA polymerase can only init...up thus forcing ARCA incorporation in the forward ...esized with conventional cap analog, 100% of the t...
RNA Cap Analog, Unmethylated from EPICENTRE Biotechnologies
Stackable Refrigerated Shaker, 230V, 50 Hz from Thermo Scientific
Biology Products: